DAFTAR PUSTAKA

1. Dorland,W.A. Kamus Kedokteran Dorland. Edisi 29. Jakarta: EGC.2002.

2. Maibach, Robertson, dan Howard. Farmakologi Dermatologik. Dalam: Katzung, Bertram
G. Farmakologi Dasar dan Klinik. Edisi VI. Jakarta: EGC. 1998. P970-87
3. Mitsos L, Sasseville D. Dermatology Rounds. Systemic Corticosteroid Use in
Dermatology: Defining, Detailing, and Demystifying. As presented in the rounds of the
Division of Dermatology McGill University Health Center. (7) : 2. Quebec. 2011.
4. Sanjay K, Rathi, dan Paschal D. Rational dan Ethical Use of opical Corticosteroids Based
on Safety and Efficacy in Indian J Dermatol. 2012 Jul-Aug; 57(4) : 251-259.
5. Jackson M.Scoot dan Lee T. Glucocorticosteroi. In: Bolognia J.L., J.L. Jorizzo,J.V.
Schaffer, Dermatology 3
rd
Ed. Elsevier: British, 2012. p2075-81
6. Warner R. Michael, Comiso Charles. Topical corticosteroid. In: Wolverton, Stephen E.
Comprehensive Dermatologic Drug Therapy, 2nd Ed. 2007; British: Elsevier. p. 595-623
7. High WA, Fitzpatrick JE. Topical Corticosteroids. In: Wolff K et al. Fitzpatricks
Dermatology in General Medicine. 7
th
ed. New York: The McGraw Hills,Inc.2008.
p.2102-06.
8. James WD, Berger TG, Elston DM. Adverse Reactions to Corticosteroids. Burns, Tony.,
et al. Topical Therapy. In:Rooks Textbook of Dermatology, 7
th
edition. Chapter 56.
London: Blackwell Publishing. 2008.75.16-21
9. Oakley A. Topical corticosteroid treatment for skin conditions. Best Practice Journal
(Internet). 2009;23.
10. C. C. Long, MRCP; A. Y. Finlay, FRCP; R. W. Averill, MD. Arch
Dermatol. 1992;128(8):1129-1130. doi:10.1001/archderm.1992.01680180125022